Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_2
4
40%
Ph early_phase_1
1
10%
Ph not_applicable
3
30%

Phase Distribution

1

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 2Efficacy & side effects
4(50.0%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)
Other(5)

Detailed Status

unknown5
Completed3
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (12.5%)
Phase 24 (50.0%)
N/A3 (37.5%)

Trials by Status

completed330%
terminated110%
unknown550%
not_yet_recruiting110%

Recent Activity

0 active trials
Showing 5 of 10
not_yet_recruitingnot_applicable

Treatment for Ph-negative ALL for Adults up to 65 Years

NCT07443592
terminatedphase_2

Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells Genetically Modified for Epidermis Restoration in Patients With Junctional Epidermolysis Bullosa

NCT05111600
completednot_applicable

Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk

NCT02757989
completed

Evolution of Interleukin 7, Fat Mass and Metabolic Profile Before and After Transplantation

NCT01414660
unknownnot_applicable

Autologous Adipose-Derived Adult Stromal Vascular Cell Transplantation for Alopecia

NCT03427905
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07443592Not Applicable

Treatment for Ph-negative ALL for Adults up to 65 Years

Not Yet Recruiting
NCT05111600Phase 2

Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells Genetically Modified for Epidermis Restoration in Patients With Junctional Epidermolysis Bullosa

Terminated
NCT02757989Not Applicable

Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk

Completed
NCT01414660

Evolution of Interleukin 7, Fat Mass and Metabolic Profile Before and After Transplantation

Completed
NCT03427905Not Applicable

Autologous Adipose-Derived Adult Stromal Vascular Cell Transplantation for Alopecia

Unknown
NCT03047772Phase 2

Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients

Unknown
NCT02932852Early Phase 1

Autologous Adipose-Derived Adult Stem Cell Transplantation for Corneal Diseases

Unknown
NCT00597519Phase 2

A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy

Completed
NCT02386332

A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies

Unknown
NCT00327314Phase 2

Non-Myeloablative Allogeneic Transplantation From Unrelated Donors in Multiple Myeloma

Unknown

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10